End of therapy minimal residual disease (MRD) measurement in children with ALL does not predict relapse

Publication date: Available online 17 June 2017 Source:Hematology/Oncology and Stem Cell Therapy Author(s): Tahani Hani Sarrawi, Ismael Zayyat, Fareed Barakat, Maha Rezeq, Salam Abu Jmaian, Faris Madanat
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research